Objective Capital Partners has consistently been recognized as a leading investment banking firm specializing in M&A, capital raising, strategic partnerships, and valuations. With more than 500 advisory engagements, we are proud to serve the transaction needs of growth stage and mid-sized companies with enterprise values of up to $250 million.(more…)
San Diego Business Journal Health Care Heros Award
San Diego, March 1, 2018 – The San Diego Business Journal’s 2018 Health Care Heroes Awards chose Objective Capital Partners’ David H. Crean, Ph.D. from among the finalists to receive the Health Care Hero Award for Company Executive for his role in healthcare innovation and support.
Leading Objective Capital Partners’ Life Sciences & Healthcare Investment Banking Practice, David leverages more than 20 years of life sciences R&D and corporate development experience. In his Managing Director role, David helps companies secure growth capital, establish strategic partnerships, and achieve exit transactions.(more…)
The Alliance of Merger & Acquisition Advisors® (AM&AA)
San Diego, January 30, 2018 — Objective Capital Partners, a middle-market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., Managing Director of the firm’s thriving Life Sciences and Healthcare practice, has been selected as the winner of the 2017 Thought Leader of the Year Award by The Alliance of Merger & Acquisition Advisors® (AM&AA).
The AM&AA recognized that “David’s thought leadership is materially expanding the investment banker’s role in serving life sciences companies and providing these companies with a highly attractive, non-diluting alternative to hard-to-secure venture capital financing.”
“We are observing life sciences and healthcare companies increasing engaging specialized investment banking teams with deep industry experience to gain a strategic advantage,” said Trever Acers, Managing Director at Objective Capital Partners. “Specialized professionals such as David and his team members at Objective Capital are engaged by experienced Life Sciences executives to significantly improve the value, probability and speed of their M&A, strategic partnering, and growth capital objectives. David is at the forefront of this change, leveraging his decades of industry experience with best-in-class investment banking capabilities to provide CEO with highly actionable strategic guidance."(more…)
San Diego, CA- December 18, 2017 – Objective Capital Partners, a middle-market M&A Advisory Firm located in Southern California, is pleased to announce that Trever Acers, a Managing Director at the firm, has been recognized by the San Diego Business Journal in the 2018 edition of the San Diego 500, The Book of Influential Business Leaders. The publication’s editorial team selected the honorees from every sector of the San Diego Business community.(more…)
San Diego, December 12, 2017 — Objective Capital Partners, a middle market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors who heads its thriving life science and healthcare practice, has been selected as top five national finalist for the 2017 Thought Leader of the Year Award by The Alliance of Merger & Acquisition Advisors® (AM&AA). For more information on the Award and the Finalists, please visit http://www.amaaonline.com/thought-leader-of-the-year/(more…)
SAN DIEGO (October 30, 2017) — Objective Capital Partners, a middle-market M&A Advisory Firm located in Southern California, is pleased to announce that it has been awarded four Advisor of the Year awards including Best Sell-side Representation by an Investment Banker for a transaction more than $25M. Objective Capital won the Advisor of the Year awards in the following categories:
- Best Sell-side Representation by an Investment Banker more than $25M for its advisory of GunVault and Cannon Safe in its sale to MidOcean Partners;
- Best Sell-side Representation by an Investment Banker less than $25M for its advisory of Troxel Helmets in its sale to Weaver Leather;
- Special Situation Advisory for its advisory of Minimal Invasive Devices in its sale to Cagan McAfee Capital Partners;
- Contribution related to Valuation for its advisory to the internal sale of an undisclosed business services company.
SAN DIEGO (October 23, 2017) — Objective Capital Partners, a middle market M&A Advisory Firm located in Southern California, is pleased to announce it has been selected as a finalist in seven categories for Advisor of the Year 2017. These awards acknowledge middle market mergers and acquisitions professionals who have significantly contributed to the successful sale, expansion or recapitalization of their clients’ companies in the San Diego region.(more…)
Information Technology Deal of the Year Finalist
New York, NY and San Diego, CA- October 11, 2017 – The M&A Advisor is pleased to announce that one of the deals represented by Objective Capital Partners, a middle-market investment banking firm located in Southern California, was selected as a Finalist in the category for Information Technology Deal of The Year for the 16th Annual M&A Advisor Awards. Objective Capital Partners served as the exclusive financial advisor to an undisclosed digital healthcare company on its confidential sale to a large private equity-backed acquirer. Two other advisers on the deal included Kirkland & Ellis LLP and Sheppard Mullin Richter & Hampton LLP. This is the third time in as many years that a deal represented by the investment banking firm was selected as a Finalist by the M&A Advisor.(more…)
San Diego, CA, May 9, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, has been announced as a finalist for Boutique Investment Banking Firm of the Year as part of the 9th Annual International M&A Advisor Awards. The M&A Advisor also recognized Objective Capital Partners as finalists in categories for Consumer Discretionary Deal of the Year and Corporate Strategic Deal of the Year ($100mm-250mm). This is the third year in a row that Objective Capital Partners has been nominated by The M&A Advisor as an award finalist.(more…)
San Diego, CA- December 13, 2016 - Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500mm, is pleased to announce that Trever Acers, a Managing Director at the firm, has been recognized and honored on 2016 San Diego County’s 500 Influential List. The list of honorees represents those business leaders in San Diego that are influential, have built and lead successful companies and stand apart for their unique roles in building our business community. The 500 List was sponsored by the San Diego Business Journal and includes leaders in a wide range of industries including business services, finance, health & science, technology, wealth & investments and icons in the community. Special recognition of honorees was held in a private reception at Hotel Del Coronado, Coronado, CA on December 1, 2016.(more…)
This article is provided for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC makes no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person.